Miliary Adenocarcinoma of the Lung Responds to Gefitinib and Afatinib.

Subjects

Subjects :

Adenocarcinoma pathology
Afatinib pharmacology
Antineoplastic Agents pharmacology
Gefitinib pharmacology
Humans
Lung Neoplasms pathology
Male
Middle Aged
Adenocarcinoma drug therapy
Afatinib therapeutic use
Antineoplastic Agents therapeutic use
Gefitinib therapeutic use
Lung Neoplasms drug therapy

Details

Language :

English

ISSN :

1556-1380

Volume :

13

Issue :

6

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Report

Accession number :

29793652

Full Text :

https://doi.org/10.1016/j.jtho.2018.01.018